L.3.8. Antibiotics and Chemotherapetic Agents

Embed Size (px)

Citation preview

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    1/37

    Antibiotics

    (anti-microbials)

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    2/37

    Introduction Kock & Pasteur over a century

    Discovered cause and effect Once found that

    Needed an agent to be created to handle them

    Antibiotics = a natural substance produced by a

    micro-organism to kill another

    Antiinfectives/Anti-microbrial = any agent (natural

    or synthetic) that kills pathogens (microbes)

    Key: it needs to kill the microbial cell and not be

    toxic to normal healthy human cells

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    3/37

    Overview Antibiotics are a large and diverse group of drugs

    which combat infections by suppressing the growth

    and reproduction of bacteria.

    Many bacteria are now resistant to antibiotics and

    some are resistant to all known agents.

    Antibiotics exploit the differencesbetween bacterial

    and human cells.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    4/37

    Classification Bacteriostatic (inhibit growth without death) or

    Bactericidal (Kill)

    Spectrum of Activity:

    Mechanism of action:

    Chemical Structure:

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    5/37

    Bacteriostatic vs Bactericidal Bacteriostatic allows for natural immunity to

    deal with the microbe

    Antibodies, Phagocytosis etc

    Bactericidial may lead to release of toxins and

    microbial contents leading to subsequentillness and inflammatory responses.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    6/37

    Spectrum of Activity Relates to the number of microbes that are susceptible to the

    action of the drug

    Narrow (limited number) / Broad (wide)

    Penicillin G is a narrow spectrum drug as it is only effectiveagainst gram-positive microbe

    Tetracyclines are effective against gram-positive and gram-negative microbes (Broad)

    Note: Never confusion these terms with potency levels of thedrugs or efficacy (ie. Narrow are weak, Broad are strong)

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    7/37

    Mechanism of Action:

    1. Inhibition of Cell Wall Synthesis

    2. Disruption of Cell Membrane

    3. Inhibition of Protein Synthesis

    4. Interference with Metabolic

    Processes

    NB:Bactericidal

    Bacteriostatic

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    8/37

    Inhibition of Cell Wall Synthesis Most bacteria possess a cell wall to protect from

    osmotic pressures

    Interrupt this leads to new microbes beingsusceptible to external influences

    Cell rupturesMicrobe death

    Disruption of the microbial cell membrane

    function. It affect cell membrane transportationin and out

    Eg. Penicillinsm, cephalosporins and

    vancomycin

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    9/37

    Inhibition of Protein Synthesis Proteins vital forgrowth and repair

    Antibiotics act either at:

    The site of protein synthesis (ribosome) or

    Within the nucleus by inhibiting synthesis of nucleic acids

    DNA replication / RNA synthesis = TRANSCRIPTION

    Eg. Tetracyclines, aminoglycosides and macrolides(erythromycin)

    Exploit structural differences between microbial andhuman cells

    High dose can lead to toxicity

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    10/37

    Interference with metabolic processes

    Agents are structurally similar to Para-

    aminobensoic acid (PABA)component of

    folic acid Essential for nucleic acid synthesis, without it

    microbes can not produce the proteins for growth

    Exploits: microbes need to create their own folic

    acid we get it in our diets.

    Eg Sulphonamides

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    11/37

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    12/37

    Antimetabolits:

    Block the functioning of metabolic pathways by

    competitively inhibiting the use of metabolitesby

    key enzymes.

    Sulfonamides and several other drugs inhibit folic

    acid metabolism.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    13/37

    Antibacterial DrugsSulfonamides or Sulfa Drugs:

    Structural analogues compete with

    metabolites in metabolic processes

    because of their similarity.

    The resulting inhibition of purineand pyrimidine synthesis leads to

    cessation of bacterial growth or

    death of the pathogen.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    14/37

    Quinolones: are synthetic drugs that

    contain the 4-quinolone ring. Ciprofloxacin,

    norfloxacin, and ofloxacin are currently

    used.

    Quinolones act by inhibiting the bacterial

    DNA gyrase or topoisomerase II, probably

    by binding to the DNA gyrase complex.

    Quinolones:

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    15/37

    Penicillin: Penicillin G or benzylpenicillin, the first

    antibiotic to be widely used in medicine.

    The mechanism of penicillin actions is still not

    completely known.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    16/37

    Cephalosporins: are a family

    of antibiotics originally

    isolated from the fungusCephalosporium, and their -

    lactam structure is very

    similar to that of the

    penicillins.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    17/37

    Antifungal DrugsTreatment of fungal infections generally has been less

    successful than that of bacterial infections largely because

    eucaryotic fungal cells are much more similar to human cells than

    are bacteria. Many drugs that inhibit or kill fungi are therefore

    quite toxic for humans.

    Nystatin is a antibiotic from Streptomyces, is used to control

    Candida infections of the skin and alimentary tract. It is thought todisrupt the mitotic spindle and inhibit cell division and it also may

    inhibit protein and nucleic acid synthesis.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    18/37

    Antiviral DrugsAntiviral drugs interfere with critical

    stages in the virus life cycle (amantadine,

    rimantadine and ritonavir)

    Inhibit the synthesis of virus specific

    nucleic acids (zidovudine, adenine

    arabinoside, Acyclovir)

    Interferon proteins inhibit virus

    replication and may be therapeutically

    useful in the future.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    19/37

    Beta-lactams

    (penicillins,

    cephalosporins)

    Broad-spectrum antibiotics*. Flucloxacillin and co-

    amoxiclav are effective against some penicillin-

    resistant organisms.

    Aminoglycosides

    (streptomycin,

    gentamicin, tobramycin)

    Effective against gram negative bacteria e.g.Pseudomonas. Reserved for serious infections e.g.septicaemia, meningitis, hospital-acquired

    pneumonia.

    Glycopeptides

    (vancomycin,

    teicoplanin)

    Effective against Staphylococci resistant to otherdrugs, including many strains of MRSA**.

    Tetracyclines(doxycycline,

    minocycline)

    Broad-spectrum antibiotics

    Table 1 Summary of some common antibiotics

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    20/37

    Macrolides

    (erythromycin)

    Broad-spectrum antibiotics, prescribed if patient is

    allergic to penicillins.

    Metronidazole Prescribed for surgical prophylaxis, bacterial

    vaginosis, pressure sores, leg ulcers.

    Quinolones

    (ciprofloxacin)

    Effective against gram negative bacteria,

    gonorrhoea, gastro-intestinal infections.

    Antitubercular drugs

    (rifampicin, isoniazid,

    rifabutin, streptomycin)

    Reserved for treatment/ containment of

    tuberculosis(TB).

    sulphonamides (co-

    trimoxazole,

    trimethoprin)

    Co-trimoxazole is reserved for serious infections

    associated with HIV/AIDS. Trimethoprin is

    prescribed for urinary tract infections.

    * Broad spectrum antibiotics are used when the infectious agent is unknown.

    Narrow spectrum antibiotics are prescribed when the micro-organisms have been identified from

    tissue samples.

    ** Many bacteria produce an enzyme which destroys beta lactam antibiotics. In addition to this,

    MRSA (methicilin-resistant Staphylococcus aureus) produces an inactivating protein which

    confers resistance to most other antibiotics.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    21/37

    Indications for antibiotics include:

    Treating bacterial infections in accordance withculture and sensitivity testing or (second best)

    knowledge of prevalent organisms.

    Prophylaxis:

    surgery e.g. gastro-intestinal surgery, joint replacement.

    meningitis contacts

    surgical/ dental procedures in patients with artificial heartvalves or heart valve lesions.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    22/37

    Administration:

    Dose depends on many factors: nature and severity of infection; weight, age and renal

    function of patient. Some doses (e.g. gentamicin, vancomycin) are determined

    by therapeutic monitoring of venous blood samples,extracted prior to dosing.

    Severe infections require intravenous infusion. Observe veins carefully for signs of phlebitis, particularly

    with penicillins and vancomycin.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    23/37

    Intramuscular injections are painful andavoided, unless essential, in children. A warmcompress may reduce pain.

    Food affects absorption (table 2).

    For other routes, see individual products(BNF).

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    24/37

    Table 2. Oral Administration of antibiotics

    Antibiotic Problem Precaution

    Tetracyclines,

    Quinolones

    Absorption impaired by

    iron, zinc or calcium in

    the stomach

    Taken either 1 hour before or 2

    hours after tablets containing these

    minerals or dairy products.

    Doxycycline

    Minocycline

    Oesophageal or gastric

    irritation

    Taken with food and a full glass of

    water

    Ampicillin

    Erythromycin Rifampicin

    Absorption reduced by

    food in the stomach

    Taken 1 hour before or 2 hours

    after meals

    Amoxycillin Absorption reduced by

    high fibre diets, e.g. bran

    or bulk laxatives e.g.

    methylcellulose

    Dose increases may be required

    Most antibiotics Absorption impaired by

    antacids, particularly

    those containing

    magnesium and

    aluminium

    Antibiotic taken 1 hour before or 2

    hours after antacids

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    25/37

    Adverse effects of antibiotics can be

    considered as:

    those occurring with all antibiotics (table 3);

    those restricted to specific agents (table 4).

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    26/37

    Table 3. Problems Associated with All Antibiotics

    Problem Precautions

    Resistance Minimise antibiotics unless bacterial sensitivity is

    known.

    Ensure adequate doses, making allowances for drug-

    food interactions.

    Complete course.

    Avoid spreading infection by observing hospital policies

    for hand-washing, asepsis, and single-use equipment.

    Try to prevent contact between MRSA and vancomycin-resistant Enterococci by separating patients harbouringthese bacteria. Such contact could allow development of

    vancomycin-resistant MRSA.

    Hypersensitivity

    1-10% of patients arehypersensitive to

    penicillins.

    Thorough patient history.

    Pre-therapy assessment of breathing pattern and skin tofacilitate detection of any changes.

    Administer intravenous therapy slowly.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    27/37

    Superinfection Minimise use of broad-spectrum antibiotics.

    Monitor fluid and electrolyte balance if diarrhoea and

    vomiting occur and be alert for Chlostridium difficileinfections.

    Small frequent meals may alleviate gastro-intestinal

    disturbance.

    Stomatitis may be alleviated by ice cubes and mouth

    care.

    Monitor for infections due to fungi (e.g. Candida),Pseudomonas, Enterobacteria.

    If aminoglycosides are administered, monitor for

    worsening of TB and Herpes infections.

    Therapeutic failure Ensure adequate doses and prompt administration.

    Certain antibiotics, particularly aminoglycosides,

    have a narrow margin between therapeutic dose andtoxicity.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    28/37

    Table 4. Toxicity associated with antibiotics

    Site Antibiotic Precaution

    Brain:

    ConvulsionsConfusion

    Penicillins

    CephalosporinsQuinolones

    aminoglycosides

    Avoid intrathecal route.

    Caution in patients with histories ofconvulsions and/or renal failure.

    Avoid co-administration of quinolones

    and NSAIDs.

    Peripheral

    nerves:

    pain,

    numbness,

    tingling

    aminoglycosides Monitor. Alternative drugs may be

    needed.

    Inner ear

    (hearing &

    balance)

    Gentamicin

    Vancomycin

    Rarely:Erythromycin

    Avoid other drugs affecting the ear.

    Avoid in pregnancy and breastfeeding,

    if possible.Ensure patient can hear and balance is

    not affected.

    Mobilise carefully.

    Monitor tinnitus.

    Administer intravenous therapy slowly.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    29/37

    Liver Erythromycin

    RifampicinIsoniazid

    Rarely:

    Tetracyclines

    Cephalosporins

    Co-amoxiclav

    Undertake liver function tests if use

    prolonged.Avoid in people with history of alcoholism.

    Pancreas Cotrimoxazole Be alert for severe vomiting and painradiating to the back.

    Check blood glucose concentration.

    Growing

    bones & teeth

    Tetracyclines

    Avoid in pregnant women & children.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    30/37

    Kidney Gentamicin

    Vancomycin

    Cotrimoxazole

    Rarely:

    CephalosporinsPenicillins

    Tetracyclines

    Check serum creatinine and urea

    to assess renal function before and

    during therapy.

    Seek alternative drug in those over

    65.Ensure adequate hydration,

    including replacing any losses due

    to diarrhoea and vomiting.

    Skin

    (photosensitivity)

    Tetracyclines,

    Quinolones

    Avoid prolonged exposure to

    sunlight. Use high factor, high star

    sunscreen

    Bone marrow Chloramphenicol

    Cotrimoxazole

    Rarely:

    Cephalosporins

    Aminoglycosides

    Avoid in patients with history/

    family history of bone marrow

    problems or taking other drugs

    potentially toxic to the marrow (e.g.

    carbimazole, carbamazepine,antipsychotics).

    Check full blood count routinely

    and if sore throat or fever develop.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    31/37

    Cautions and contraindications

    History of hypersensitivity - Patients allergic tocephalosporins are often allergic to penicillins and

    vice versa. Patients allergic to diuretics or celecoxibor oral hypoglycaemics may be allergic tosulphonamides.

    Glandular fever (Epstein-Barr virus infection),cytomegalovirus infection greatly increase the riskof developing a penicillin-induced rash.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    32/37

    Impaired renal function causes some drugs to

    accumulate e.g. penicillins, tetracyclines,

    vancomycin, ciprofloxacin, teicoplanin.

    Impaired liver function causes some drugs to

    accumulate e.g. metronidazole, rifampicin.

    Myasthenia gravis. Aminoglycosides and

    quinolones exacerbate this condition.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    33/37

    Porphyria. Avoid sulphonamides, cephalosporins,erythromycin, flucloxacillin, rifampicin, trimethoprin

    Pregnancy: Penicillins are usually the antibiotics of firstchoice. Tetracyclines, trimethoprin, cotrimazole,glycopeptides and aminoglycosides are avoided if possible.

    Breastfeeding allows small amounts of antibiotic to passfrom mother to infant. Hypersensitivity responses andadverse effects may occur in the infant. Breastfeeding is notadvised in some severe infections.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    34/37

    Drug Interactions

    Adverse effects are cumulative when drugs causing similarproblems are co-administered. For example, drugs damagingthe inner ear (e.g. gentamicin, vancomycin, teicoplanin,cisplatin, furosemide), are rarely combined (table 4).

    Susceptible people suffer an antabuse-like reaction if theytake even a small amount of alcohol with certain antibiotics,

    usually metronidazole or cephamandole. This results indilatation of all the blood vessels, causing flushing, severeheadache and profound hypotension. Faints, falls andcardiovascular collapse may follow.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    35/37

    Oral contraceptives Rifampicin and rifabutin render all oral contraceptives

    ineffective. All broad spectrum antibiotics increase the risk of 'pill

    failure' for combined oral contraceptives.

    Many antibiotics are incompatible with other drugs

    when co-administered in intravenous infusions. Forexample, if gentamicin is combined with heparin or a

    penicillin, its antibiotic activity will be lost.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    36/37

    Aminoglycosides intensify the action of muscle

    relaxants such as suxamethonium. Their use

    must be highlighted when the patient istransferred to the anaesthetic team.

    Macrolides cause accumulation of other drugse.g. digoxin, corticosteroids, anti-coagulants.

  • 7/30/2019 L.3.8. Antibiotics and Chemotherapetic Agents

    37/37

    Textbook References

    Karch AM (2006) Focus on Nursing Pharmacology,3rd Edition. Lippincott Williams & Wilkins

    Rang et al (2003) Pharmacology, 5th Edition.

    Churchill Livingstone. Lilley et al (2005) Pharmacology and the Nursing

    Process, 4th Edition. Mosby

    Page et al (2002) Integrated Pharmacology, 2ndEdition. Mosby.

    Martini (2005) Principles of Anatomy andPhysiology, Pearson Education Publishers